Ageing, metabolic immunodepression and carcinogenesis.
D000328:Adult; D000368:Aged; D000375:Aging; D002471:Cell Transformation, Neoplastic / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000188:drug therapy; D004734:Energy Metabolism / Q000187:drug effects; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D007111:Immunity, Cellular / Q000187:drug effects; D007153:Immunologic Deficiency Syndromes / Q000276:immunology / Q000378:metabolism*; D007328:Insulin / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology*; D010629:Phenformin / Q000627:therapeutic use; D011247:Pregnancy; D014280:Triglycerides / Q000097:blood
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D002784:Cholesterol; D010629:Phenformin; D002994:Clofibrate